Get the Stockscreener App
185.83
0.38%
-0.70
Pre-market:
185.54
-0.29
-0.16%
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $185.83, with a volume of 1.54M.
It is down -0.38% in the last 24 hours and down -0.12% over the past month.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.
See More
Previous Close:
$186.53
Open:
$187.93
24h Volume:
1.54M
Relative Volume:
0.81
Market Cap:
$53.26B
Revenue:
$21.39B
Net Income/Loss:
$1.61B
P/E Ratio:
33.42
EPS:
5.5609
Net Cash Flow:
$2.55B
1W Performance:
-1.73%
1M Performance:
-0.12%
6M Performance:
-9.11%
1Y Performance:
-22.12%
1-Day Range:
$185.71
$188.52
1-Week Range:
$185.71
$193.43
52-Week Range:
$163.33
$251.99
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
185.83 | 53.46B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ISRG
Intuitive Surgical Inc
|
546.51 | 195.43B | 9.61B | 2.77B | 2.27B | 7.555 |
|
RMD
Resmed Inc
|
259.49 | 38.71B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
76.08 | 37.70B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
297.47 | 22.09B | 2.96B | 487.70M | 344.00M | 6.6758 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-25-25 | Initiated | RBC Capital Mkts | Sector Perform |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
Will Becton Dickinson and Company stock outperform Dow Jones2025 Sector Review & Daily Oversold Bounce Ideas - newser.com
Technical signs of recovery in Becton Dickinson and CompanyJuly 2025 Drop Watch & Free Community Supported Trade Ideas - newser.com
Is Becton Dickinson and Company (BOX) stock a buy during volatile markets2025 Growth vs Value & Smart Allocation Stock Reports - newser.com
Is Becton Dickinson and Company (BOX) stock inflation resilientMarket Performance Summary & Proven Capital Preservation Tips - newser.com
Is Becton Dickinson and Company meeting your algorithmic filter criteriaJuly 2025 Highlights & AI Forecast Swing Trade Picks - newser.com
Should you hold or exit Becton Dickinson and Company nowSwing Trade & Free Expert Verified Stock Movement Alerts - newser.com
Will Becton Dickinson and Company stock profit from fiscal stimulusWall Street Watch & Long-Term Investment Growth Plans - newser.com
Becton Dickinson Gives South West Blood Bikes a New Permanent Home in Plymouth - Plymouth Chronicle
What Makes Becton Dickinson & Co. (BDX) a Good Investment? - MSN
Becton, Dickinson & Co. Experiences Revision in Its Stock Evaluation Amid Market Challenges - Markets Mojo
Becton, Dickinson and Company Stock: Is Wall Street Bullish or Bearish? - MSN
Here's What to Expect From Becton, Dickinson & Company’s Next Earnings Report - inkl
GCC $1.25+ Bn Catheter Market Growth Trends and Forecast to 2033 Featuring Abbott, Edwards Lifesciences, BD and Co, Boston Scientific, Medtronic, Johnson & Johnson, Stryker, Teleflex - Yahoo Finance
Will Becton Dickinson and Company see short term momentumMarket Trend Review & Real-Time Volume Analysis Alerts - newser.com
BD simplifies at-home HPV testing with new self-collection solution By Investing.com - Investing.com South Africa
BD simplifies at-home HPV testing with new self-collection solution - Investing.com Australia
BD (NYSE: BDX) unveils IVDR-certified at-home HPV self-collection with 30-day stability - Stock Titan
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Long term hold vs stop loss in Becton Dickinson and CompanyMarket Growth Review & AI Driven Price Forecasts - newser.com
BD launches AI-powered Incada Platform for healthcare connectivity - Medical Device Network
Is Becton Dickinson and Company stock a fit for income portfoliosJuly 2025 Catalysts & Advanced Technical Signal Analysis - newser.com
Waters-Becton, Dickinson deal cleared to close in Brazil - MLex
Becton, Dickinson and Company: A Dividend Idea With Diverse Medtech Portfolio To Meet Future Demand - Seeking Alpha
BD launches AI-enabled platform to connect medical devices By Investing.com - Investing.com Australia
BD launches AI-enabled platform to connect medical devices - Investing.com
What to do if you’re stuck in Becton Dickinson and CompanyAnalyst Downgrade & Daily Price Action Insights - newser.com
BD Launches New AI-enabled Solutions to Drive Connectivity Across Healthcare Settings - MarketScreener
Nearly 3M connected BD devices — BD's Incada™ AI Platform and Pyxis™ Pro unify device data - Stock Titan
Becton, Dickinson and Company (BDX) Stock Analysis: Evaluating a 10.14% Potential Upside - DirectorsTalk Interviews
Published on: 2025-10-19 00:28:03 - nchmf.gov.vn
Becton Dickinson's CFO to depart - MSN
Sell Signal: Will Becton Dickinson and Company stock benefit from green energy trends2025 Trade Ideas & Free Safe Capital Growth Stock Tips - nchmf.gov.vn
Published on: 2025-10-18 04:48:02 - nchmf.gov.vn
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
RBC Capital reiterates Sector Perform rating on Becton Dickinson stock By Investing.com - Investing.com Canada
Evaluating Becton Dickinson and Company with trendline analysisNew Guidance & Smart Investment Allocation Insights - newser.com
Becton Dickinson stock falls on weak Q4 sales, CFO departure news - Investing.com Canada
Becton Dickinson stock falls on weak Q4 sales, CFO departure news By Investing.com - Investing.com South Africa
BD CFO Set To Exit Company This December, Stock Falls - Benzinga
Exclusive: Ulta Beauty's new CFO is a Johnson & Johnson veteran tasked to help lead the company's next chapter - Fortune
Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $200 - 富途牛牛
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Announces Target Price $211 - 富途牛牛
RBC Capital reiterates Sector Perform rating on Becton Dickinson stock - Investing.com
CFO to leave Becton Dickinson after four years - medwatch.com
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $190 - 富途牛牛
U.S. Stocks Movement | Becton Dickinson & Co Drops Over 3% Pre-Market Despite Q4 Revenue Growth; Lowers Full-Year Sales Outlook - 富途牛牛
Becton Dickinson Delivers Steady Growth But Misses Revenue Mark - Finimize
BD announces CFO transition plan, preliminary Q4 results - MassDevice
BD Announces CFO Transition Plan - citybiz
Becton Dickinson Posts Preliminary 4Q, FY Results - 富途牛牛
Becton, Dickinson (BDX) Faces Revenue Projections Below Expectat - GuruFocus
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.18%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):